Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.

Inclusion Criteria:

• Six month history of migraine; attacks typically mild when they begin with 1-4 migraine attacks per month.

Exclusion Criteria:

• Heart disease
• High blood pressure